Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis
- 16 November 2015
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 2 (1), 8-31
- https://doi.org/10.1021/acsinfecdis.5b00093
Abstract
Despite the tremendous improvement in overall global health heralded by the adoption of the Millennium Declaration in the year 2000, tropical infections remain a major health problem in the developing world. Recent estimates indicate that the major tropical infectious diseases, namely, malaria, tuberculosis, trypanosomiasis, and leishmaniasis, account for more than 2.2 million deaths and a loss of approximately 85 million disability-adjusted life years annually. The crucial role of chemotherapy in curtailing the deleterious health and economic impacts of these infections has invigorated the search for new drugs against tropical infectious diseases. The research efforts have involved increased application of computational technologies in mainstream drug discovery programs at the hit identification, hit-to-lead, and lead optimization stages. This review highlights various computer-aided drug discovery approaches that have been utilized in efforts to identify novel antimalarial, antitubercular, antitrypanosomal, and antileishmanial agents. The focus is largely on developments over the past 5 years (2010-2014).Keywords
Funding Information
- University of Capetown
- Department of Science and Technology, Republic of South Africa
- South African Medical Research Council
This publication has 100 references indexed in Scilit:
- Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High-Throughput Screening Program against the Novel Malarial Target, PfNDH2: Increasing Hit Rate via Virtual Screening MethodsJournal of Medicinal Chemistry, 2012
- The future of molecular dynamics simulations in drug discoveryJournal of Computer-Aided Molecular Design, 2011
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Identification of Novel Non-Hydroxamate Anthrax Toxin Lethal Factor Inhibitors by Topomeric Searching, Docking and Scoring, and in Vitro ScreeningJournal of Chemical Information and Modeling, 2009
- Automated Docking Screens: A Feasibility StudyJournal of Medicinal Chemistry, 2009
- Quantitative Three Dimensional Structure Linear Interaction Energy Model of 5′-O-[N-(Salicyl)sulfamoyl]adenosine and the Aryl Acid Adenylating Enzyme MbtAJournal of Medicinal Chemistry, 2008
- Inhibition of Siderophore Biosynthesis in Mycobacterium tuberculosis with Nucleoside Bisubstrate Analogues: Structure−Activity Relationships of the Nucleobase Domain of 5′-O-[N-(Salicyl)sulfamoyl]adenosineJournal of Medicinal Chemistry, 2008
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2006
- GRAMM-X public web server for protein-protein dockingNucleic Acids Research, 2006